Caricamento...
Adolescent Asthma Pharmacotherapy in a State of Flux
Recently, the United States Food and Drug Administration (FDA) elected not to approve a once-daily inhaled corticosteroid/long-acting β2 agonist combination product in 12–17-year-old patients due to lack of sufficient data, despite approval of previous combination products with similar levels of sup...
Salvato in:
| Pubblicato in: | Pediatr Allergy Immunol Pulmonol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mary Ann Liebert, Inc.
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4580303/ https://ncbi.nlm.nih.gov/pubmed/26421215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ped.2015.0562 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|